NCT06525051View on ClinicalTrials.gov

Effect of Tiotropium on Eye Findings in the Treatment of Chronic Obstructive Pulmonary Disease

CompletedOBSERVATIONAL

Enrollment

108

Participants

Timeline

Start Date

October 23, 2023

Primary Completion Date

March 30, 2024

Study Completion Date

April 30, 2024

Conditions

Chronic Obstructive Pulmonary DiseaseGlaucoma, Angle-Closure

Interventions

DRUG

Tiotropium

Tiotropium is a long-acting anticholinergic agent and has a bronchodilator effect. According to the COPD Gold 2024 guideline, it is one of the long-acting bronchodilator drugs used as the first choice in the treatment of group A COPD patients.

Trial Locations (1)

28100

Giresun Training and Research Hospital, Giresun

All Listed Sponsors

lead

Giresun University

OTHER

NCT06525051 - Effect of Tiotropium on Eye Findings in the Treatment of Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter